scispace - formally typeset
N

Nicola D. Kerrison

Researcher at University of Cambridge

Publications -  43
Citations -  2872

Nicola D. Kerrison is an academic researcher from University of Cambridge. The author has contributed to research in topics: Population & Genome-wide association study. The author has an hindex of 19, co-authored 36 publications receiving 1793 citations.

Papers
More filters
Journal ArticleDOI

An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans

Robert A. Scott, +216 more
- 01 Nov 2017 - 
TL;DR: This article conducted a meta-analysis of genome-wide association data from 26,676 T2D case and 132,532 control subjects of European ancestry after imputation using the 1000 Genomes multiethnic reference panel.
Journal ArticleDOI

Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study.

TL;DR: The authors found that the relative effect of a type 2 diabetes genetic risk score is greater in younger and leaner participants, and the high absolute risk associated with obesity at any level of genetic risk highlights the importance of universal rather than targeted approaches to lifestyle intervention.
Journal ArticleDOI

Validity of a short questionnaire to assess physical activity in 10 European countries

TL;DR: The validity of a brief PA questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) is examined, finding the EPIC-PAQ is suitable for categorizing European men and women into four distinct categories of overall physical activity.
Journal ArticleDOI

Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study.

TL;DR: A collaborative re-analysis of data from the InterAct case-control study has established that waist circumference is associated with risk of type 2 diabetes, independently of body mass index.
Journal ArticleDOI

Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity

TL;DR: Protective associations were driven by MC4R variants exhibiting signaling bias toward β-arrestin recruitment and increased mitogen-activated protein kinase pathway activation, which may represent an effective strategy for weight loss and the treatment of obesity-related cardiometabolic diseases.